G/LIC/N/2/HKG/14  
 
25 February  2020 
(20-1444) Page: 1/3 
Committee on Import Licensing  Original: English  
 
 AGREEMENT ON IMPORT LICENSING PROCEDURES  
NOTIFICATION UNDER A RTICLE 5.1 TO 5.4 OF  THE AGREEMENT1 
HONG KONG, CHINA 
  
The following notification dated  24 February 2020 , is being circulated at the request of the delegation 
of Hong Kong, China . 
 
 Category  Notification details  
1 Notifying Member  Hong Kong, China  
2 Title of new 
legislation/procedure  Implementation of phase II of Pharmaceuticals Licence 
Application and Movement Monitoring System (PLAMMS)  
3 Date of Publication  
 27 December 2019  
4 Date of entry into force  
 30 December 2019  
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.drugoffice.gov.hk   
6 Have you attached a copy 
of the regulation (PDF) to 
the Secretariat  
  Yes. ( Please attach a copy of the regulation to the 
notification. ) 
 
No. 
7 Type of notification   (a) New licensing regulation/procedure2; (please answer 
question 8 to 14)  
 
 (b) Changes to a regulation/procedure which has been 
previously notified in document: G/LIC/N/ 2/HKG/7 ;  ( please 
answer question 15 and 16 ) 
8 List of products subject  
to licensing  Please provide the HS codes and detailed descriptions of the 
products. In case of a long list, please attach the list as an 
Annex in MS WORD document.  
 
9 Nature of licensing  Automatic:  
 
Non-Automatic:  
 
 
 
1 It is understood that the notifying Member has also completed its notification obligations under 
Article  1.4(a) and Article 8.2(b) regarding the relevant law/regulation/procedure notified for by filling this form 
in a full and complete manner.  
2 "New licensing regulation/procedure" is understood to refer to any newly introduced law, regulation or 
procedure, and those which are in force but being no tified for the first time to the Committee.  
 G/LIC/N/2/HKG/14  
 
- 2 - 
 
   Category  Notification details  
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; 
protect environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, 
and the prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and 
other international treaties ( i.e. CITES, Basel 
Convention, Rotterdam Convention, UNSC 
Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or 
fissionable materials and safeguard national 
security;  
(h)  Other: ______________ (please specify)  
 
11 Administrative body(ies) 
for 
submission of 
applications   
 Ministry/authority and Department: [ ]  
Address: [ ]  
Website: [ ]  
Telephone: [ ]  
E-Mail: [ ]  
12 Contact point for 
information on eligibility  Ministry/authority and Department: [ ]  
Address: [ ]  
Website: [ ]  
Telephone:  [ ]  
E-Mail: [ ]  
 
13 Expected duration of 
licensing procedure   
 
14 A summary of the 
notification in one of the 
WTO official languages    
 
 
15 In the case of 7(b), 
please indicate the type 
of new change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in 
existing procedures:  
 Product coverage;  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of 
application;  
 Documentation requirements (including application 
form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  G/LIC/N/2/HKG/14  
 
- 3 - 
 
   Category  Notification details  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other:  Providing an electronic platform for 
application submission  
 
16  Please elaborate the 
changes in detail (in one 
of the WTO official 
languages)  
 The Pharmaceuticals License Application and Movement 
Monitoring System (PLAMMS) is a web -based internet and 
intranet system provided for all licensees, Product 
registration Certificate holders and Drug Office users. 
Phase  I of PLAMMS was launched in 2014.  
 
The second phase of PLAMMS further extended its scope to 
include import/export licence processing of registered 
pharmaceutical products; dangerous drugs; unregistered 
pharmaceutical products for the treatment of particular 
patients /animals by a registered medical 
practitione r/dentist/veterinary surgeon; pharmaceutical 
products for the purpose of clinical trials/medicinal test; and 
pharmaceutical products or substances imported by a 
pharmaceutical manufacturer for the purpose of manufacture 
of pharmaceutical products.  
 
 
__________